StockStory Flags Flat Revenue and Falling Returns at STAAR Surgical
The publisher cited two years of flat revenue, declining returns and a 22.7-times forward earnings multiple in its bearish assessment.
Key takeaways
- STAAR Surgical revenue was flat over the two years cited by StockStory.
- StockStory said the company’s return on invested capital had declined over several years.
StockStory said it sees risks in STAAR Surgical, citing flat revenue, declining returns on invested capital and the stock’s valuation. The publisher’s Oct. 12 article listed shares at $21.50.
The article said revenue had been flat over the prior two years and totaled $339.6 million over the past 12 months. StockStory also said return on invested capital had fallen significantly over the last few years.
At the cited share price, StockStory put the stock at 22.7 times forward earnings. It said the company fell short of its quality standards, but did not name the digital advertising platform it said it preferred.
This article was produced with the help of AI technology. Source: Yahoo Finance
